Is a 5mg formulation of hydralazine (direct vasodilator) available?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydralazine 5mg Formulation Availability

No, a 5mg formulation of hydralazine is not available in standard clinical practice. The lowest recommended starting doses are substantially higher than 5mg across all clinical indications.

Available Formulations and Dosing

Intravenous Formulation

  • The initial IV dose for hypertensive emergencies is 10-20 mg as a slow bolus, repeated every 4-6 hours as needed 1, 2, 3
  • No 5mg IV formulation exists in standard practice 2, 3

Oral Formulations

  • Conventional tablets: The lowest starting dose is 25-50 mg administered three to four times daily 1, 4
  • Fixed-dose combination (with isosorbide dinitrate): Starts at 37.5 mg hydralazine/20 mg isosorbide dinitrate three times daily 1
  • Slow-release formulation: Studied at doses of 200 mg once daily, not available in 5mg strength 5, 6

Clinical Context for Dosing

Heart Failure with Reduced Ejection Fraction

  • Initial dosing begins at 25-50 mg three to four times daily, always combined with isosorbide dinitrate 1, 4
  • Target dose is 75 mg hydralazine three times daily (225 mg total daily) 1
  • Mean dose achieved in clinical trials was approximately 175 mg total daily 1
  • Maximum daily dose is 300 mg in divided doses 1, 4

Hypertension Management

  • Oral dosing for blood pressure control starts at 25-50 mg three to four times daily 4, 7
  • Studies demonstrate no need to administer hydralazine more than twice daily when combined with beta-blockers and diuretics 5, 8, 6

Important Clinical Considerations

A 5mg dose would be subtherapeutic for all approved indications. The pharmacokinetic profile and dose-response relationship of hydralazine require substantially higher doses to achieve clinical benefit 7, 8:

  • The daily dose that elicits 50% of maximum antihypertensive response (D50) is 0.87 mg/kg for slow acetylators and 1.68 mg/kg for fast acetylators 7
  • For a 70kg patient, this translates to approximately 60-120 mg daily minimum for half-maximal effect 7
  • Maximum antihypertensive response (Emax) is 9.4 mm Hg, achieved with doses well above 5mg 7

Common Pitfall to Avoid

  • Never attempt to use hydralazine at doses below 10mg IV or 25mg oral, as these doses fall far below the therapeutic threshold established in clinical trials and pharmacokinetic studies 1, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hydralazine Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hydralazine Dosing Protocol for Acute Blood Pressure Control

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Oral Hydralazine Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hydralazine once daily in hypertension.

British medical journal (Clinical research ed.), 1982

Research

Hydralazine dose-response curve analysis.

Journal of pharmacokinetics and biopharmaceutics, 1990

Research

Duration of hydralazine action in hypertension.

Clinical pharmacology and therapeutics, 1975

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.